Introduction of our experiences in histopathological analyses for IPF

Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which is a clinically representative mouse model that can be used to conduct drug efficacy studies for idiopathic pulmonary fibrosis (IPF).


Histological endpoints are necessary in order to accurately assess and understand the pathological changes that occur in the target tissue due to the disease, as well as the effects that potential drug candidates have.


As a CRO, we have successfully evaluated histological images in over 150 pharmacology studies in the IPF model, the results of which were summarized and sent back to our clients.

In addition to actually staining the images, our highly skilled histopathologists also assess the pathology from multi-faceted viewpoints utilizing both quantitative and qualitative analysis. To see some examples of the histological stains that can be used in this model, please see below:



If you would like to receive more information on our IPF model or our experience conducting histopathological analyses, please do not hesitate to contact us.

We would also be happy to arrange a Zoom meeting with our marketing and science team to briefly explain what services we offer and how we might support your project.